A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Abroad (travel likely)RecruitingPHASE2
Conditions
Systemic Sclerosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Galderma Investigational Site # 8743, Ann Arbor, Michigan, United States
Contact: Study coordinator (Galderma Project Manager)Galderma Investigational Site#7096, Arlington, Texas, United States
Contact: Study coordinator (Galderma Project Manager)Galderma Investigational Site # 6213, Sankt Gallen, Switzerland
Contact: Study coordinator (Galderma Project Manager)